Li Ying

Managing Director

13 past transactions

Phabuilder

Series A in 2023
PhaBuilder is a technology company specializing in synthetic biology, particularly in the transformation and engineering of halophilic microbes. Founded in February 2021 by Professor Guoqiang Chen, the company employs advanced methodologies to develop high-value products such as biodegradable polyhydroxyalkanoates (PHA), ectoine for pharmaceuticals, and cadaverine for nylon production. PhaBuilder is currently constructing two PHA production facilities, one in Beijing and another in Yichang, with plans to establish three to five large-scale production sites across China within five years. The company has successfully completed two rounds of financing, securing approximately 300 million yuan from notable investors. PhaBuilder aims to integrate synthetic biotechnology into various aspects of daily life and enhance the intelligent biological manufacturing sector, aspiring to fulfill its mission of utilizing microbes to foster a sustainable and eco-friendly future.

Sanmean

Series A in 2021
Sanmean is a store that provides prefabricated, semi-finished products. They offer home-prepared dishes, which makes three meals a day more convenient and lively. They provide delicious meal solutions to consumers.

Changyang Tech

Series C in 2020
Changyang Technology (Beijing) Co., Ltd. is a technical enterprise specializing in industrial Internet security and critical infrastructure protection. Founded in 2017 and located in Haidian District, China, the company offers a comprehensive range of services and solutions, including security protection, monitoring and auditing, vulnerability scanning, security testing tools, and industrial terminal security. Additionally, Changyang Technology focuses on fostering security situational awareness and leveraging big data applications to enhance its offerings. With seven distinct product lines, the firm is dedicated to providing robust industrial Internet of Things security solutions, ensuring the safety and integrity of critical infrastructure.

Xiaolvren

Series A in 2017
Xiaolvren is a Chinese company specializing in the development of electric bike charging infrastructure. The company offers a range of products, including smart charging piles and a cloud management platform for charging stations. Users can easily initiate the charging process by scanning a QR code, with payments facilitated through their smartphones. By focusing on innovative solutions for electric bike charging, Xiaolvren aims to support the growing demand for sustainable transportation options in urban environments.

Thinker Corporation

Series A in 2013
Thinker Corporation manufactures consumer healthcare and oral therapeutic self-care products and solutions. It offers acme cleansing and gingival effervescent tablets and ACTIMINS, which is a bioactive ingredient toothpaste for plaque index reduction and gingivitis index. Thinker Corporation was formerly known as Beijing Thinker Times Tech Co., Ltd. and changed its name to Thinker Corporation in August 2014. The company was founded in 2011 and is headquartered in Beijing, China.
Twenty First Century Aerospace Technology Co., Ltd specializes in commercial earth observation (EO) satellites and offers a wide array of data and information services. The company operates a constellation of small EO satellites capable of capturing high-resolution images and manages satellite control, image tasking, and receiving stations. Its comprehensive services encompass satellite procurement, operational management, data acquisition, image processing, and distribution, along with advanced geo-information services tailored for various applications. The company develops proprietary algorithms and software systems to ensure high-quality image data collection and processing. Its offerings include land cover imagery, change detection, data analysis, and 3D simulations, supporting sectors such as government administration, public services, and industrial applications. Founded in 2001 and based in Beijing, the company aims to leverage its technologies for applications in urban management, resource monitoring, disaster response, and environmental management, serving both Chinese and global markets.

Shenogen Pharma Group

Series A in 2011
Shenogen Pharma Group is a drug discovery and development company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.